Advertisement

Tyrosine kinase inhibitors, gene remedy might lower moist AMD therapy burden


Thank you for reading this post, don't forget to subscribe!

July 14, 2025

1 min watch

LAS VEGAS — On this video from Medical Trials on the Summit, Lejla Vajzovic, MD, FASRS, of Duke Eye Middle, discusses tyrosine kinase inhibitors and gene remedy as totally different approaches for moist age-related macular degeneration.

“I do anticipate and I do imagine there will likely be higher enhancements in visible acuities down the street, and we will likely be not solely preserving imaginative and prescient for these sufferers however bettering it as nicely,” Vajzovic instructed Healio.